Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002284 · ClinicalTrials.gov registry record · NA
A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
A NA study of HIV Infections and Lymphoma, Non-Hodgkin, sponsored by Glaxo Wellcome.
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00002284 is a NA study of HIV Infections and Lymphoma, Non-Hodgkin that has completed, run by Glaxo Wellcome. The trial reports 1 study location across 1 state.
The verdict
NCT00002284, a NA study of HIV Infections and Lymphoma, Non-Hodgkin, has completed, sponsored by Glaxo Wellcome.
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
To determine whether zidovudine (AZT) in conjunction with bone marrow transplantation prevents the reinfection of donor hematopoietic/lymphoid cells in patients with positive HTLV III antibody and large cell/diffuse histiocytic lymphoma. Patients who are candidates will be evaluated for HTLV III activity and drug levels.
Conditions Studied
Interventions
- DRUG Zidovudine
Study Locations (1)
Maryland
- Johns Hopkins Hemapheresis Treatment Ctr - Baltimore
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002284
The ClinicalTrials.gov registry entry for NCT00002284 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Glaxo Wellcome, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Zidovudine is the first listed.
NCT00002284 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00002284 about?
NCT00002284 is a clinical study titled "A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant". To determine whether zidovudine (AZT) in conjunction with bone marrow transplantation prevents the reinfection of donor hematopoietic/lymphoid cells in patients with positive HTLV III antibody and large cell/diffuse histiocytic lymphoma. Patients who are candidates will be evaluated for HTLV III act...
What is the current status of trial NCT00002284?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002284 study?
This clinical trial studies the following conditions: HIV Infections, Lymphoma, Non-Hodgkin.
What interventions are being tested in trial NCT00002284?
The interventions under investigation include: Zidovudine (DRUG).
Who is sponsoring clinical trial NCT00002284?
This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002284 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.